Centessa Pharmaceuticals (CNTA) Long-Term Debt Issuances (2020 - 2021)
Centessa Pharmaceuticals (CNTA) reported Long-Term Debt Issuances of $73.9 million for Q4 2021, up 97376.32% year-over-year from N/an in Q4 2020, and up 97376.32% on a QoQ basis from -$76000.0 in Q4 2020.
Centessa Pharmaceuticals (CNTA) has 2 years of Long-Term Debt Issuances data on file, last reported at $73.9 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 73.93 Mn |
| Dec 31, 2021 | 73.93 Mn |
| Dec 31, 2020 | -76,000.00 |
| Dec 31, 2020 | -76,000.00 |